Skip to main content Back to Top
Advertisement

7/26/2019

Azithromycin Injection

Products Affected - Description

    • Zithromax intravenous lyophilized powder for injection, Pfizer, 500 mg, vial, 10 count, NDC 00069-3150-83
    • Azithromycin intravenous lyophilized powder for injection, Apotex, 500 mg, vial, 10 count, NDC 60505-6076-04 - discontinued
    • Azithromycin intravenous lyophilized powder for injection, AuroMedics, 500 mg, vial, 10 count, NDC 55150-0174-10
    • Azithromycin intravenous lyophilized powder for injection, Pfizer, 500 mg, ADD-Vantage vial, 10 count, NDC 00409-0144-11
    • Azithromycin intravenous lyophilized powder for injection, Sun Pharma, 500 mg, vial, 10 count, NDC 62756-0512-44

Reason for the Shortage

    • Apotex has discontinued azithromycin injection.
    • AuroMedics did not provide a reason for the shortage.
    • Fresenius Kabi had azithromycin injection on shortage due to increased demand.
    • Pfizer has azithromycin injection on shortage due to manufacturing delays.
    • Slate Run Pharmaceuticals has azithromycin injection available.
    • Sun Pharma is not currently manufacturing azithromycin injection.

Available Products

    • Azithromycin intravenous lyophilized powder for injection, Athenex, 500 mg, vial, 10 count, NDC 70860-0100-10
    • Azithromycin intravenous lyophilized powder for injection, Fresenius Kabi, 500 mg, vial, 10 count, NDC 63323-0398-10
    • Azithromycin intravenous lyophilized powder for injection, Slate Run Pharmaceuticals, 500 mg, vial, 10 count, NDC 70436-0019-82

Estimated Resupply Dates

    • AuroMedics has azithromycin 500 mg vials on intermittent back order and the company is releasing product as it becomes available.
    • Pfizer has azithromycin 500 mg ADD-Vantage vials on back order and the company estimates a release date of March 2020. Zithromax 500 mg vials are on back order and the company estimates a release date of October 2019.

Updated

Updated July 26, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 14, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins